Description

Mounjaro Price

Mounjaro (tirzepatide) is used for type 2 diabetes to help lower blood sugar levels and improve A1C (glycemic control) in adults and children 10 years and older, in addition to diet and exercise. Mounjaro has also been shown to produce significant weight loss and maintain the lost weight in clinical trials when combined with diet and exercise. It is a once-weekly injection that can be self-administered at home. Mounjaro Price

Mounjaro works by activating two gut hormone receptors, GIP and GLP-1, to manage blood sugar. This triggers insulin release when blood sugar rises, reduces glucagon secretion from the liver, slows digestion to prevent post-meal sugar spikes, and helps you feel fuller for longer. All of these effects work together to lower blood sugar levels, improve A1C, and reduce how much you eat.

Mounjaro belongs to the class of medications called dual GIP/GLP-1 receptor agonists (glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonists).

Mounjaro (tirzepatide) gained FDA approval on May 13, 2022. There is no Mounjaro generic. The 2 different brands of tirzepatide (Mounjaro and Zepbound) are made by Eli Lilly and Company but are FDA-approved for different conditions.

Possible thyroid tumors (Including Cancer)

Warnings. Mounjaro may cause tumors in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If you have any of these symptoms, tell your healthcare provider. Mounjaro Price

• Do not use Mounjaro if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).
• Do not use Mounjaro if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Do not use Mounjaro if you are allergic to it or any of the ingredients in Mounjaro.